Protective Role of C3aR (C3a Anaphylatoxin Receptor) Against Atherosclerosis in Atherosclerosis-Prone Mice

Lin-Lin Wei1, Ning Ma1, Kun-Yi Wu1

  • 1From the Core Research Laboratory (L.-L.W., N.M., K.-Y.W., J.-X.W., T.-Y.D., S.-J.Z., K.L.), Xi'an Jiaotong University, China.

Abstract

Insights

The C3a anaphylatoxin receptor (C3aR) plays a protective role in atherosclerosis. Its absence exacerbates disease by increasing inflammation and promoting pro-inflammatory M1 macrophage polarization.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Complement System

Background:

  • Emerging evidence indicates protective roles for C3a anaphylatoxin receptor (C3aR) signaling in inflammatory diseases.
  • The specific role of C3aR in atherosclerosis remains largely unknown.

Purpose of the Study:

  • To investigate the potential protective role of C3aR in aortic atherosclerosis.
  • To explore the underlying molecular and cellular mechanisms involved in C3aR-mediated protection.

Main Methods:

  • Generation of C3aR-deficient/ApoE-deficient (C3ar-/-/Apoe-/-) mice by cross-breeding.
  • Assessment of atherosclerotic plaque burden, aortic tissue inflammation, leukocyte infiltration, and systemic inflammatory responses in mice fed a high-fat diet for 16 weeks.
  • In vitro analysis of peritoneal macrophages stimulated with C3a.

Main Results:

  • C3ar-/-/Apoe-/- mice exhibited more severe atherosclerosis compared to Apoe-/- controls.
  • Absence of C3aR led to increased local production of pro-inflammatory mediators (CCL2, TNF-α) and enhanced monocyte/macrophage infiltration with an M1-like phenotype in aortic lesions.
  • Mice lacking C3aR showed heightened systemic inflammatory responses, including elevated plasma CCL2 and TNF-α levels.
  • In vitro, C3a stimulation promoted anti-inflammatory M2 macrophage polarization while suppressing M1 polarization.

Conclusions:

  • C3aR plays a protective role in the development of atherosclerosis.
  • The C3a/C3aR axis confers protection by negatively regulating pro-inflammatory responses.
  • C3aR modulates macrophage polarization towards an anti-inflammatory phenotype, thereby mitigating atherosclerosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
250
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
593
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
742